title: Suppression, subversion and escape: the role of regulatory T cells in cancer progression.
abstract: Regulatory T cells (T(regs) ) are crucial in mediating immune homeostasis and promoting the establishment and maintenance of peripheral tolerance. However, in the context of cancer their role is more complex, and they are thought to contribute to the progress of many tumours. As cancer cells express both self- and tumour-associated antigens, T(regs)  are key to dampening effector cell responses, and therefore represent one of the main obstacles to effective anti-tumour responses. Suppression mechanisms employed by T(regs)  are thought to contribute significantly to the failure of current therapies that rely on induction or potentiation of anti-tumour responses. This review will focus on the current evidence supporting the central role of T(regs)  in establishing tumour-specific tolerance and promoting cancer escape. We outline the mechanisms underlying their suppressive function and discuss the potential routes of T(regs)  accumulation within the tumour, including enhanced recruitment, in-situ or local proliferation, and de-novo differentiation. In addition, we review some of the cancer treatment strategies that act, at least in part, to eliminate or interfere with the function of T(regs) . The role of T(regs)  is being recognized increasingly in cancer, and controlling the function of these suppressive cells in the tumour microenvironment without compromising peripheral tolerance represents a significant challenge for cancer therapies.
authors.affiliation: Chemokine Research Group, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
authors.forename: K
authors.initials: K
authors.lastname: Oleinika
authors.forename: R J
authors.initials: RJ
authors.lastname: Nibbs
authors.forename: G J
authors.initials: GJ
authors.lastname: Graham
authors.forename: A R
authors.initials: AR
authors.lastname: Fraser
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018450:Disease Progression; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects / Q000276:immunology*; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology*; D011379:Prognosis; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects / Q000276:immunology*; D019139:Tumor Escape / Q000187:drug effects / Q000276:immunology*; D059016:Tumor Microenvironment / Q000276:immunology
chemical_list: D000970:Antineoplastic Agents